Compare EMO & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EMO | INMD |
|---|---|---|
| Founded | 2011 | 2008 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 851.8M | 879.2M |
| IPO Year | N/A | 2019 |
| Metric | EMO | INMD |
|---|---|---|
| Price | $44.48 | $14.28 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $16.75 |
| AVG Volume (30 Days) | 27.1K | ★ 571.9K |
| Earning Date | 01-01-0001 | 02-10-2026 |
| Dividend Yield | ★ 6.70% | N/A |
| EPS Growth | N/A | ★ 20.42 |
| EPS | N/A | ★ 2.21 |
| Revenue | N/A | ★ $364,494,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $3.76 |
| P/E Ratio | ★ N/A | $7.07 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $26.42 | $13.14 |
| 52 Week High | $40.17 | $19.78 |
| Indicator | EMO | INMD |
|---|---|---|
| Relative Strength Index (RSI) | 51.30 | 43.97 |
| Support Level | $43.65 | $14.30 |
| Resistance Level | $45.16 | $15.72 |
| Average True Range (ATR) | 0.70 | 0.37 |
| MACD | -0.01 | 0.05 |
| Stochastic Oscillator | 38.54 | 2.07 |
ClearBridge Energy Midstream Opportunity Fund Inc is a non-diversified, closed-end management investment company. Its investment objective is to provide long-term investors with a high level of total return with an emphasis on cash distributions. The Fund considers investments in midstream entities as those entities that provide midstream services including the gathering, transporting, processing, fractionation, storing, refining, and distribution of oil, natural gas liquids and natural gas.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.